Navigation Links
Pig Pancreas Cells Help Type 1 Diabetics
Date:5/6/2010

Early trial finds technique is safe, improves blood sugar control

THURSDAY, May 6 (HealthDay News) -- Pancreatic cells from pigs that have been encapsulated have been successfully transplanted into humans without triggering an immune system attack on the new cells.

What's more, scientists report, the transplanted pig pancreas cells quickly begin to produce insulin in response to high blood sugar levels in the blood, improving blood sugar control in some, and even freeing two people from insulin injections altogether for at least a short time.

"This is a very radical and new way of treating diabetes," said Dr. Paul Tan, CEO of Living Cell Technologies of New Zealand. "Instead of giving people with type 1 diabetes insulin injections, we deliver it in the cells that produce insulin that were put into capsules."

The company said it is slated to present the findings in June at the American Diabetes Association annual meeting in Orlando, Fla.

The cells that produce insulin are called beta cells and they are contained in islet cells found in the pancreas. However, there's a shortage of available human islet cells. For this reason, Tan and his colleagues used islet cells from pigs, which function as human islet cells do.

"These cells are about the size of a pinhead, and we place them into a tiny ball of gel. This keeps them hidden from the immune system cells and protects them from an immune system attack," said Tan, adding that people receiving these transplants won't need immune-suppressing drugs, which is a common barrier to receiving an islet cell transplant.

The encapsulated cells are called Diabecell. Using a minimally invasive laparoscopic procedure, the covered cells are placed into the abdomen. After several weeks, blood vessels will grow to maintain the islet cells, and the cells begin producing insulin.

The company recently released data from its initial safety trial. The
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Artificial Pancreas Helps Type 1 Diabetics During Sleep
2. Artificial Pancreas Prototype in Development for Type 1 Diabetics
3. Solid-pseudopapillary neoplasm of the pancreas or pancreatic endocrine tumor?
4. Artificial Pancreas for Type 1 Diabetes Moves Closer to Reality
5. UCSF Researchers Identify Regulator of Human Sperm Cells
6. Loss of gene function makes prostate cancer cells more aggressive
7. Mechanism discovered by which bodys cells encourage tuberculosis infection
8. Scientists discover enzyme that cleans cancer cells
9. Fat Tissue May Be a Source of Valuable Blood Stem Cells, Study Says
10. Stem cell breakthrough: Bone marrow cells are the answer
11. Researchers find leukemia cells metabolize fat to avoid cell death
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... May 21 (HealthDay News) -- Urban elementary school ... experience sleep problems and suffer academically, new research ... aged seven to nine, we found that compromised ... and impaired academic performance," said study author ... human behavior at Brown University,s Alpert Medical School ...
(Date:5/21/2013)... Minn. Positively charged gold nanoparticles are usually ... to avoid nanoparticle toxicity. Mayo Clinic researchers found ... nanoparticles effective against ovarian cancer cells. The discovery ... the Journal of Biological Chemistry ., "This ... cancer cells by preventing the cell death or ...
(Date:5/21/2013)... May 21, 2013 Representatives with Hammerhead Bicycles ... a success that the company has achieved its overall goal ... day one was to move Hammerhead Bicycles from a house ... President Scott Robertson. , Robertson explained that the bike shop ... to exclusively focus on all things 29er and 650b. ...
(Date:5/21/2013)... the sound of galloping hooves behind you, your immediate reaction ... it is actually a zebra approaching. Doctors are trained to ... their practices, and as they rarely or never meet a ... takes many years to reach the right diagnosis. A new ... many cases. , Ole Winther is Associate Professor at ...
(Date:5/21/2013)... (PRWEB) May 21, 2013 Two-thirds of ... non-small cell lung cancer reported that they engage in ... medicine use, according to new findings from the ... Kantar Health . The research will be presented ... (International Society for Pharmacoeconomics and Outcomes Research) in New ...
Breaking Medicine News(10 mins):Health News:Sleepless Nights May Hurt School Performance of Kids With Asthma 2Health News:Mayo Clinic: How gold nanoparticles can help fight ovarian cancer 2Health News:Hammerhead Bicycles Now a Standalone Brand 2Health News:New search engine finds rare diagnoses 2Health News:New search engine finds rare diagnoses 3Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 2Health News:Two in Three Cancer Patients are Non-Adherent with Their Medications, According to Kantar Health Research 3
... (ASX: PGL; Nasdaq: PGLA) announced today that its ... status by the U.S. Food,and Drug Administration (FDA). ... 88 for the prevention of tumor recurrence following ... primary liver,cancer). Under the FDA Modernization Act ...
... Urgent Health Problems Report Highest Satisfaction When Seen by ... , Patient satisfaction with after-hours care for an urgent ... physician or their physicians after-hours clinic, compared with a ... services. According to a survey of 1,227 patients from ...
... seldom questioned, study found , , MONDAY, Sept. 24 (HealthDay ... some of their neediest patients, a new study suggests ... that raise suicide risk. , U.S. researchers recruited ... showing signs of depression or a similar disorder. , ...
... for her contributions to kidney ... ... a nationwide patient advocacy group comprised of more than 20,000,dialysis and pre-dialysis ... Entitled, Celebrating the Empowerment of,Kidney Patients, the event brought together dialysis patients ...
... N.C., Sept. 24 SalesForce4Hire(R), a provider of,custom ... Science industries,today announced the opening of its new ... allows SalesForce4Hire to expand its custom sales focus ... size of its sales,support call center. This new ...
... Robust Clinical Data Package Provided in NDA Demonstrates ... Safety of Once-Daily Tramadol Formulation, LAVAL, QC, Sept. ... announced that is has requested a meeting with the ... Drug,Application (NDA) for its once-daily formulation of tramadol. Based ...
Cached Medicine News:Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 2Health News:US FDA Fast Tracks PI-88 for the Treatment of Post Resection Liver Cancer 3Health News:September/October 2007 Annals of Family Medicine tip sheet 2Health News:September/October 2007 Annals of Family Medicine tip sheet 3Health News:September/October 2007 Annals of Family Medicine tip sheet 4Health News:September/October 2007 Annals of Family Medicine tip sheet 5Health News:September/October 2007 Annals of Family Medicine tip sheet 6Health News:September/October 2007 Annals of Family Medicine tip sheet 7Health News:Doctors Often Fail to Spot Suicidal Patients 2Health News:Doctors Often Fail to Spot Suicidal Patients 3Health News:Nation's Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care 2Health News:Nation's Largest Dialysis Patient Organization Recognizes the Achievements of Patients and Leaders in Kidney Care 3Health News:SalesForce4Hire Opens New Office 2Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 2Health News:Labopharm provides update on U.S. regulatory process for once-daily Tramadol 3
(Date:5/21/2013)... Calif. , May 21, 2013 Abaxis, ... blood analysis systems, announced today that Martin ... at the Stifel Annual Dental & Veterinary Conference on ... conference will be held at Le Parker Meridien Hotel ... About Abaxis Abaxis develops, manufactures, markets ...
(Date:5/21/2013)... JUPITER, Fla. , May 21, 2013  BioRestorative ... a life sciences company focused on developing stem cell ... Mark Weinreb , its President and CEO, ... The conference will be held on Thursday, ... at 109 E 42nd Street in New York City.  ...
(Date:5/21/2013)... 2013 Ceregene, Inc. today announced additional ... double-blind, randomized, controlled Phase 2b clinical study of ... designed to deliver the neurotrophic factor neurturin, for ... robust response to CERE-120 in Parkinson,s patients diagnosed ... those diagnosed 10 years or more (p<.005), as ...
Breaking Medicine Technology:Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 2Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 3Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 4Ceregene Reports Additional Efficacy Data From Parkinson's Disease Phase 2b Study 5
... Nov. 18, 2010 The Pharmacy Technician ... Melissa Murer Corrigan, will serve as the 2011 president ... be installed at the ICE Annual Education Conference on ... organization that provides educational, networking and advocacy resources for ...
... 2010 Cell Therapeutics, Inc. ("CTI") (Nasdaq and ... Application ("MAA") seeking approval for Pixuvri™ (pixantrone dimaleate) ... relapsed or refractory aggressive non-Hodgkin,s lymphoma ("NHL") was ... Medicines Agency ("EMA"). Validation indicates that the application ...
Cached Medicine Technology:Melissa Murer Corrigan to Serve as 2011 ICE President 2The European Medicines Agency Validates and Accepts Cell Therapeutics' Marketing Authorization Application for Pixuvri™ 2The European Medicines Agency Validates and Accepts Cell Therapeutics' Marketing Authorization Application for Pixuvri™ 3
... a Q-switched ruby laser system ... nm. High Performance Combined with ... combination of high performance and ... mode effectively destroys the (natural ...
A Powerful New Quantitative Immunoassay for Monitoring Bladder Cancer Patients. Useful in Monitoring Patients for,Disease Progression and Recurrence....
... Test is an in vitro immunoassay intended for ... tumor associated antigen. It is indicated for use ... cancer in conjunction with cystoscopy or when prescribed ... by the FDA for prescription home use in ...
... is a quantitative microplate enzyme immunoassay that detects ... have very small amounts of NMP22 protein in ... is often elevated in the urine of patients ... the disease. The use of the NMP22 protein ...
Medicine Products: